On December 16, 2025, Jeffrey Lightcap, a member of HeartFlow’s Board of Directors (NASDAQ:HTFL), purchased 40,000 common shares in an open-market transaction valued at $1,053,680, according to SEC Form 4. The transaction price was reported at $26.34, reflecting the market close on the same day. HeartFlow utilizes advanced AI and computational fluid dynamics to provide non-invasive cardiac diagnostics, enhancing patient outcomes and operational efficiency for healthcare providers. This technology addresses significant limitations of traditional imaging methods.
